Stocks · Healthcare · Biotechnology
REGENXBIO Inc. RGNX
$7.76 +4.44% Close, Oct 5, 2026 · NASDAQ · Market cap $384.1M
Strong growthWeak trendHigh risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -94.1% from -105.7% a year earlier.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- The stock is 51% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 44%
- Revenue growth, 3-year CAGRTop 41%
- Revenue growth accelerationTop 5%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 23%
- Gross marginBottom 39%
- Operating marginBottom 29%
- Accruals (lower is better)Bottom 6%
- Interest coverBottom 43%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 15%
- Free-cash-flow yieldBottom 6%
- EBITDA / enterprise valueBottom 20%
- Sales / enterprise valueTop 30%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 28%
- 6-month returnBottom 30%
- 1-year return vs S&P 500Bottom 25%
- Distance from 52-week highBottom 26%
- Trend checklist (0–4)Bottom 13%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 4%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 31%
- Upside to consensus price targetTop 25%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 12%
- Maximum drawdown, 3 yearsBottom 36%
- Beta vs S&P 500 (lower is better)Bottom 4%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -44.0% | 12.0% | ↑ |
| Gross margin | 79.9% | 54.2% | ↓ |
| Operating margin | -105.7% | -94.1% | ↑ |
| FCF margin | -58.2% | -143.1% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 12.0% | -44.0% | ↑ | Top 44% |
| Gross margin | 54.2% | 79.9% | ↓ | Bottom 39% |
| Operating margin | -94.1% | -105.7% | ↑ | Bottom 29% |
| Net margin | -112.6% | -112.7% | ↑ | — |
| Free-cash-flow margin | -143.1% | -58.2% | ↓ | — |
| Return on invested capital | -52.7% | — | Bottom 23% | |
| Revenue growth, 3-year CAGR | 14.8% | — | Top 41% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 13.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 20.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +384.8 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -3.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -5.43%
- Shareholder yield
- -5.43%
- Share count change, 1 year
- +3.0%
- Share count change, 3-year CAGR
- +6.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- +100.0%
- Average 2-day reaction, last 8
- -4.1%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $19.60
- Target vs current price
- +152.6%
- Analysts with a rating
- 20
- Share rating Buy or Strong Buy
- 65%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +446.2% | +7.4% | +3.9% | -8.6% | — |
| May 14, 2026 | -26.5% | -37.7% | -40.5% | -37.5% | +3.8% |
| Mar 5, 2026 | -28.7% | -4.6% | +2.6% | -5.6% | -23.3% |
| Nov 6, 2025 | +13.0% | -3.8% | -0.1% | +11.8% | -6.5% |
| Aug 7, 2025 | -22.1% | -4.0% | +8.5% | +14.5% | +55.8% |
| May 12, 2025 | -70.7% | +6.0% | +18.2% | +26.7% | +9.4% |
| Mar 13, 2025 | +20.5% | -1.8% | +27.4% | -11.4% | +44.1% |
| Nov 6, 2024 | -0.9% | +5.7% | +17.6% | +2.7% | -5.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $0.43 | $0.08 | +446.2% | $108.0M |
| May 14, 2026 | -$1.72 | -$1.36 | -26.5% | $6.4M |
| Mar 5, 2026 | -$1.30 | -$1.01 | -28.7% | $30.3M |
| Nov 6, 2025 | -$1.20 | -$1.38 | +13.0% | $29.7M |
| Aug 7, 2025 | -$1.38 | -$1.13 | -22.1% | $21.4M |
| May 12, 2025 | $0.12 | $0.41 | -70.7% | $89.0M |
| Mar 13, 2025 | -$1.01 | -$1.27 | +20.5% | $21.2M |
| Nov 6, 2024 | -$1.17 | -$1.16 | -0.9% | $24.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 2.39× | — | — | Top 30% |
| Free-cash-flow yield | -65.00% | — | — | Bottom 6% |
| Earnings yield | -48.84% | — | — | Bottom 15% |
P/E over the past five years
Range 9.7× – 17.6× since Dec 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -15.7%
- 200-day average slope (20 days)
- -4.6%
- Distance from 50-day average
- -16.0%
- Distance from 200-day average
- -21.2%
- RSI (14)
- 42.1
- Relative volume
- 1.65×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 89.9%
- Volatility vs own 5-year history
- 82th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.63
- Correlation with S&P 500
- 0.43
- Current drawdown from 1-year high
- -51.4%
- Maximum drawdown, 3 years
- -78.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 14, 2021 | Apr 8, 2025 | -89.4% | 1062 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $384.1M
- EPS, diluted (TTM)
- -$3.79
- Revenue (TTM)
- $174.5M
- 52-week range
- $5.46 – $16.19
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $470.3M | $112.7M | $90.2M | $83.3M | $170.4M |
| Gross profit | $418.5M | $58.2M | $53.0M | $49.8M | $150.1M |
| Operating income | $160.0M | -$262.9M | -$268.1M | -$233.3M | -$161.2M |
| Net income | $127.8M | -$280.3M | -$263.5M | -$227.1M | -$193.9M |
| EPS (diluted) | $2.91 | -$6.50 | -$6.02 | -$4.59 | -$3.76 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.2M | $21.2M | $89.0M | $21.4M | $29.7M | $30.3M | $6.4M | $108.0M |
| Net income | -$59.6M | -$51.2M | $6.1M | -$70.9M | -$61.9M | -$67.1M | -$90.1M | $22.7M |
| EPS (diluted) | -$1.17 | -$1.01 | $0.12 | -$1.38 | -$1.20 | -$1.30 | -$1.72 | $0.43 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $218.9M | -$207.5M | -$218.4M | -$173.1M | -$124.0M |
| Capital expenditure | -$84.2M | -$30.7M | -$10.0M | -$2.4M | -$2.4M |
| Free cash flow | $134.7M | -$238.2M | -$228.4M | -$175.6M | -$126.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $218.2M | $1.7M | $6.7M | $132.3M | $1.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $105.5M
- Total assets
- $386.6M
- Total liabilities
- $314.9M
- Total debt
- $69.0M
- Net debt
- $32.5M
- Shareholders’ equity
- $71.8M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 7,927,603
- Days to cover
- 7.66
- Change vs previous report
- +5.7%
FINRA short interest, settlement date Sep 15, 2026.